Stereoselective Oxidation Reactions by Thomas Wirth

Get full text

Neue Methode zur reduktiven Desaminierung primärer aliphatischer Amine by Thomas Wirth, Christoph Rüchardt

Get full text

Beyond FOXO1: AS1842856 inhibits GSK3 to enhance cytotoxic effects in B-ALL by Franz Ketzer, Ulrike Büttner, Daniel Geist, Anita Kick, Thomas Wirth, Alexey Ushmorov

Get full text

Multi-target gene therapy AUP1602-C to improve healing and quality of life for diabetic foot ulcer patients: a phase I, open-label, dose-finding study by Christoph Schindler, Jacek Mikosiński, Pawel Mikosiński, Hanna-Riikka Kärkkäinen, Mirka Sanio, Jere Kurkipuro, Igor Mierau, Wesley Smith, Aki Vartiainen, Laurent Décory, Dirk Weber, Thomas Wirth, Juha Yrjänheikki, Sebastian Schellong, Haritha Samaranayake

Get full text

Low triglyceride levels are associated with increased risk of immune-related adverse events in patients receiving immune checkpoint inhibitors by Nora Möhn, Emily Narten, Laura Duzzi, Janin Thomas, Lea Grote-Levi, Gernot Beutel, Tabea Fröhlich, Benjamin-Alexander Bollmann, Thomas Wirth, Imke von Wasielewski, Ralf Gutzmer, Florian Heidel, Frank Pessler, Walter Zobl, Sven Schuchardt, Philipp Ivanyi, Sandra Nay, Thomas Skripuletz

Get full text

Characterization of Hospital Admissions During Immune Checkpoint Inhibitor Therapy: Insights From the ICOG Study by Jonas Paul Wiegmann, Tabea Fröhlich, Nora Möhn, Laura Duzzi, Emily Narten, Johanna Aurich, Janin Thomas, Lea Grote‐Levi, Susann Mahjoub, Dominik Berliner, Thomas Wirth, Heiko Golpon, Benjamin‐Alexander Bollmann, Imke Von Wasilewski, Ralf Gutzmer, Florian H. Heidel, Thomas Skripuletz, Gernot Beutel, Philipp Ivanyi, ICOG‐CCCH (Immune Cooperative Oncology Group, Comprehensive Cancer Center Hannover)

Get full text